CDMO produces clearly identifiable labelling for a top-ten pharmaceutical company
Ravensburg, Germany, April 28, 2015 / B3C newswire / -- Vetter has today announced the manufacture of the first commercial batches with single-use identification numbers. Following the introduction of a comprehensive serialization service last year, the company has now implemented product serialization for secondary packaging for one of the world's leading pharmaceutical companies. In accordance with the requirements from the South Korean Ministry of Food and Drug Safety (MFDS) Vetter's solution identifies the drugs on the folding boxes via a 2-D data matrix code with a serial number, GTIN, expiry date, and batch number.
As the number of counterfeit drugs continues to grow, regulatory authorities around the world are increasingly relying on clear identification of products through serialization. They are demanding that the smallest packaging unit be marked with a single-use identification number. South Korea is among those countries requiring serialization with an aim towards protecting against counterfeiting, as well as a more secure supply chain.
"Together with our customer, we prepared for these requirements very early on," says Thomas Otto, managing director at Vetter. "We have been active in filling and final packaging for the company for years. Thanks to our serialization service, our partner can now meet the regulatory requirements for South Korea. We are, however, also aware of the fact that regulatory requirements differ from one country to the next. Therefore, we offer pharma and biotech companies a wide range of options that will give them flexibility when reacting to different regulatory standards."
Presently, South Korea has only asked for serialization on the folding package. China, however, has legislated use of 1-D linear codes including aggregation with the shipping box. As such, Vetter provides a broad variety of services in secondary packaging, primary packaging and final assembly that give its customers a great deal of flexibility to accommodate various regulatory or market needs. The company's comprehensive serialization service includes a range of formats for serial numbers, different code systems; such as a 2-D data matrix codes, interfaces and reports, as well as various aggregation depths. Pharmaceutical and biotech companies can use Vetter's individually customizable solutions as basis for their own track-and-trace programs to optimize their supply chain.
Caption: Vetter completes first commercial serialization project for South Korea
For high resolution please click the image.
About Vetter
Vetter is a premier contract development and manufacturing organization (CDMO) and a global leader in the fill and finish of aseptically prefilled syringe systems, cartridges and vials. Headquartered in Ravensburg, Germany, with facilities in Germany and the United States, the company provides state-of-the-art manufacturing, from early clinical development through commercial filling and packaging of parenteral drugs. The CDMO’s extensive experience covers a broad range of complex compounds, including monoclonal antibodies, peptides and interferons. Vetter supports its customers every step of the way, guiding their products through development, regulatory approval, launch and lifecycle management. Known for quality, the company offers a foundation of experience spanning more than 35 years, including dozens of product approvals for novel bio/ pharmaceutical compounds. Since 2014, Vetter operates a representative office in Singapore, increasing the presence of the company and the awareness of its service portfolio in the Asian healthcare market.
Contact
Vetter Pharma International GmbH
Oskar Gold
Senior Vice President Key Account Management,
Marketing / Corporate Communications
Eywiesenstrasse 5
88212 Ravensburg
+49 (0)751-3700-3706
This email address is being protected from spambots. You need JavaScript enabled to view it.